Markets
2.1
BioNTech swings to Q3 profit, lifts 2026 revenue guidance
Published 2 d ago1 sourceEvidence: Reported
Anadolu Agency ENDE
MarketsReportedMedium
5.0
SK Biopharm Q3 Operating Profit Surges 66% on U.S. Seizure Drug Sales
SK Biopharmaceuticals reported a 66% year-on-year increase in Q3 operating profit, driven by strong U.S. sales of its seizure drug. The earnings beat signals robust commercial execution, though sustainability depends on continued market share gains and competitive dynamics.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Score Breakdown
Mosaic Score5.0
Model confidence0.7
Significance0.5
Source credibility0.2
Intelligence Tags
Locations
Seoul
Entities
United StatescountrySouth Koreacountry
Related signals
8 foundMarkets
6.4
Novo Raises Full-Year Targets; Analyst Sees Gradual Turnaround
Published 1 d ago6 sourcesEvidence: Reported
SeverityModerateDagens IndustriLow-rated sourceSE
Markets
5.6
Novo Nordisk Q3 beats on Wegovy pill, but Eli Lilly lead persists
Published 1 d ago3 sourcesEvidence: Reported
SeverityModerateFDLow-rated sourceDK · US
Markets
5.2
Novo raises full-year sales forecast after Q3 beat, operating profit misses
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateDagens IndustriLow-rated sourceDK
Markets
5.1
Kakao Bank posts record earnings on higher interest and non-interest income
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateYonhap ENLow-rated sourceKR
Markets
5.1
Coupang swings to Q3 loss on warehouse fire-related costs
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateYonhap ENLow-rated sourceKR
Markets
5.0
KT&G Q3 Net Profit Plunges 75.1% on FX Losses
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateYonhap ENLow-rated sourceKR
Markets
4.8
AstraZeneca bids ~$9.7B for Rhythm Pharmaceuticals
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateAssessedDeveloping storyDagens IndustriLow-rated sourceSE · US